Table 1.
Clinical and pathological data from 37 patients with GBCA presented as intraluminal mass, and 28 patients with GBCA presented as infiltrating tumor (mean ± SD) n (%)
| Intraluminal mass | Infiltrating tumor | P value | |
| Age (yr)2 | 65.49 ± 1.51 | 73.07 ± 1.90 | 0.020a |
| Sex ratio (female)1 | 23 (62.1) | 18 (64.3) | 0.861 |
| RUQ or epigastric pain or discomfort1 | 28 (75.7) | 23 (82.1) | 0.530 |
| Jaundice1 | 3 (8.1) | 13 (46.4) | < 0.001a |
| Fever1 | 3 (8.1) | 10 (35.7) | 0.006a |
| Incidental finding | 7 (18.9) | 3 (8.1) | 0.364 |
| Aspartate aminotransferase (IU/L)2 | 89.36 ± 101.14 | 74.37 ± 88.62 | 0.914 |
| Alanine aminotransferase (IU/L)2 | 113.21 ± 103.97 | 78.87 ± 82.04 | 0.252 |
| Alkaline phosphatase (IU/L)2 | 119.36 ± 87.80 | 220.68 ± 164.84 | 0.030a |
| Total bilirubin (mg/dL)2 | 1.74 ± 2.87 | 3.50 ± 3.51 | 0.011a |
| Presence of gallstones1 | 12 (32.4) | 22 (78.6) | < 0.001a |
| Gallbladder size | |||
| Length (cm)2 | 7.47 ± 1.70 | 6.47 ± 1.83 | 0.032a |
| Width (cm)2 | 4.21 ± 1.43 | 2.67 ± 0.93 | 0.026a |
| T1 tumor1 | 8 (21.7) | 1 (3.6) | 0.038a |
| T2 tumor1 | 11(29.7) | 9 (32.1) | 0.835 |
| T3 tumor1 | 17 (45.9) | 16 (57.1) | 0.267 |
| T4 tumor1 | 1 (2.7) | 2 (7.2) | 0.581 |
| Metastatic lymph nodes1 | 13 (35.1) | 15 (53.6) | 0.712 |
| Survival < 12 mo1 | 16 (43) | 18 (68) | 0.017a |
1
Fisher's exact test or χ2 test;
2
Wilcoxon rank sum test;
a
Significant at 0.05; RUQ: Right upper quadrant; GBCA: Gallbladder carcinoma.